AlphaCentric Advisors’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
Other funds holding BEAM
KCM
AlphaCentric Advisors's BEAM Position: Q3 2026 in Review
AlphaCentric Advisors opened a new position in Beam Therapeutics (BEAM) in Q3 2026: 14,322 shares worth $350K. The stake represents 0.31% of the portfolio and ranks #102 among its holdings.
220 funds tracked by Wall St. Rank hold BEAM as of Q3 2026.
- AlphaCentric Advisors held 14,322 shares of Beam Therapeutics worth $350K as of Q3 2026.
- Beam Therapeutics was a new AlphaCentric Advisors position in Q3 2026.
- Beam Therapeutics made up 0.31% of AlphaCentric Advisors's portfolio in Q3 2026, its #102 holding.
- 220 funds tracked by Wall St. Rank held Beam Therapeutics as of Q3 2026.
Based on AlphaCentric Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.